000538 云南白药
已收盘 11-26 15:00:00
资讯
新帖
简况
李楚源“落马”3个月后,广药集团新董事长定了!
市场资讯 · 11-26 21:03
李楚源“落马”3个月后,广药集团新董事长定了!
云南白药(000538.SZ)每10股派12.13元 股权登记日为11月22日
智通财经 · 11-18
云南白药(000538.SZ)每10股派12.13元 股权登记日为11月22日
云南白药:11月11日接受机构调研,麦格理资本参与
证券之星 · 11-13
云南白药:11月11日接受机构调研,麦格理资本参与
11月6日云南白药发布公告,其股东增持1669.72万股
证券之星 · 11-06
11月6日云南白药发布公告,其股东增持1669.72万股
云南白药(000538.SZ)第一大股东已累计增持0.98%公司股份
智通财经 · 11-06
云南白药(000538.SZ)第一大股东已累计增持0.98%公司股份
报告:牙膏市场线上贡献率近四成 参半口腔、云南白药领跑
新浪财经 · 11-06
报告:牙膏市场线上贡献率近四成 参半口腔、云南白药领跑
云南白药第三季度净利润下滑,人事密集调整能否走出高层动荡?
21世纪经济报道 · 11-03
云南白药第三季度净利润下滑,人事密集调整能否走出高层动荡?
云南白药(000538)2024年三季报简析:营收净利润同比双双增长
证券之星 · 10-31
云南白药(000538)2024年三季报简析:营收净利润同比双双增长
云南白药(000538.SZ)发布前三季度业绩,净利润43.27亿元,同比增长4.93%
智通财经 · 10-30
云南白药(000538.SZ)发布前三季度业绩,净利润43.27亿元,同比增长4.93%
云南白药最新公告:第三季度净利润为11.38亿元 同比下降12.16%
证券之星 · 10-29
云南白药最新公告:第三季度净利润为11.38亿元 同比下降12.16%
云南白药:建链、数字化与新纪元│信心中国·英华万里行
中国基金报 · 10-24
云南白药:建链、数字化与新纪元│信心中国·英华万里行
云南白药最新公告:聘任李胜利为公司高级副总裁
证券之星 · 10-11
云南白药最新公告:聘任李胜利为公司高级副总裁
10月9日云南白药跌7.39%,易方达沪深300医药ETF基金重仓该股
证券之星 · 10-09
10月9日云南白药跌7.39%,易方达沪深300医药ETF基金重仓该股
云南白药:9月19日接受机构调研,招商基金、海通证券参与
证券之星 · 09-20
云南白药:9月19日接受机构调研,招商基金、海通证券参与
云南白药:9月12日接受机构调研,南方基金、博时基金等多家机构参与
证券之星 · 09-14
云南白药:9月12日接受机构调研,南方基金、博时基金等多家机构参与
云南白药“窝案”后,白云山前董事长李楚源、前董事张春波也遭调查!
市场资讯 · 09-02
云南白药“窝案”后,白云山前董事长李楚源、前董事张春波也遭调查!
换帅之后业绩创历史新高,云南白药做对了什么
证券之星 · 08-31
换帅之后业绩创历史新高,云南白药做对了什么
【工信部到云南白药集团调研】金十数据8月28日讯,据云南白药消息,8月23日,工信部消费品工业司副司长王孝洋一行在云南省工信厅相关负责人的陪同下到云南白药集团调研,进一步了解云南省医药产业发展情况,推动云南省医药产业高质量发展。
美港电讯 · 08-28
【工信部到云南白药集团调研】金十数据8月28日讯,据云南白药消息,8月23日,工信部消费品工业司副司长王孝洋一行在云南省工信厅相关负责人的陪同下到云南白药集团调研,进一步了解云南省医药产业发展情况,推动云南省医药产业高质量发展。
云南白药(000538)2024年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-28
云南白药(000538)2024年中报简析:营收净利润同比双双增长,盈利能力上升
云南白药(000538)6月30日股东户数17.71万户,较上期减少8.03%
证券之星 · 08-27
云南白药(000538)6月30日股东户数17.71万户,较上期减少8.03%
加载更多
公司概况
公司名称:
云南白药集团股份有限公司
所属行业:
医药制造业
上市日期:
1993-12-15
主营业务:
云南白药集团股份有限公司是一家主要经营化学原料药、化学药制剂、中成药、中药材、生物制品等的公司。公司产品以云南白药系列、三七系列和云南民族特色药品系列为主,共17种剂型200余个产品,产品畅销国内市场及东南亚一带,并逐渐进入日本、欧美等发达国家市场。公司是我国知名中成药生产企业之一,是云南大型工商医药企业之一,是中国中成药五十强之一。2022年12月,由北京大学社会调查研究中心和智联招聘联合主办的“中国年度最佳雇主”评选揭晓,云南白药集团荣膺“2022中国最佳雇主”殊荣。
发行价格:
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":56.52,"timestamp":1732604634000,"preClose":57.02,"halted":0,"volume":6721882,"delay":0,"floatShares":1769000000,"shares":1784000000,"eps":2.4083,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.5,"latestTime":"11-26 15:00:00","open":56.56,"high":57.36,"low":56.31,"amount":381000000,"amplitude":0.0184,"askPrice":56.53,"askSize":42,"bidPrice":56.52,"bidSize":13,"shortable":0,"etf":0,"ttmEps":2.4083,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732671000000},"adr":0,"adjPreClose":57.02,"symbolType":"stock","openAndCloseTimeList":[[1732584600000,1732591800000],[1732597200000,1732604400000]],"highLimit":62.72,"lowLimit":51.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"pbRate":2.51,"roa":"--","roe":"10.82%","epsLYR":2.29,"committee":-0.015437,"marketValue":100847000000,"floatMarketCap":100006000000,"peRate":23.468838,"changeRate":-0.0088,"turnoverRate":0.0038,"status":1},"requestUrl":"/m/hq/s/000538","defaultTab":"news","newsList":[{"id":"2486535070","title":"李楚源“落马”3个月后,广药集团新董事长定了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2486535070","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486535070?lang=zh_cn&edition=full","pubTime":"2024-11-26 21:03","pubTimestamp":1732626180,"startTime":"0","endTime":"0","summary":"广药集团核心子公司白云山新任董事长会是谁? 广药集团前董事长李楚源辞任并“落马”后,空悬了4个月的董事长一职终于有了新人选。2023年2月,广州市政府任命李小军为广州公交集团董事长。至今,李楚源落马已有三月。 李楚源离任后,副董事长杨军将代为履行董事长职责,直至选举新任董事长。目前,白云山尚未公告新任董事长人选。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-26/doc-incxmcye7311483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","600436","600332","BK0028","BK0096","BK0175","BK0239","BK0164","BK0012","BK0187","BK0196","BK0070","BK0097","000538","BK0188"],"gpt_icon":0},{"id":"2484764000","title":"云南白药(000538.SZ)每10股派12.13元 股权登记日为11月22日","url":"https://stock-news.laohu8.com/highlight/detail?id=2484764000","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484764000?lang=zh_cn&edition=full","pubTime":"2024-11-18 19:08","pubTimestamp":1731928137,"startTime":"0","endTime":"0","summary":"智通财经APP讯,云南白药(000538.SZ)发布公告,公司将实施2024年特别分红权益分派,每10股派发现金红利12.13元(含税),股权登记日为11月22日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000538","BK0187","BK0188","BK0239","BK0175","BK0028","BK0012","BK0196","BK0164"],"gpt_icon":0},{"id":"2483917070","title":"云南白药:11月11日接受机构调研,麦格理资本参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2483917070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483917070?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:05","pubTimestamp":1731495954,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月13日云南白药发布公告称公司于2024年11月11日接受机构调研,麦格理资本Tony Ren 高茜白 戚瑜洁参与。2023 年,云南白药分红方案为每 10 股派息 20.77 元,现 金分红总额 37.06 亿元,占 2023 年归母净利润比例 90.53%,公司已 于 2024 年 5 月 10 日完成年度权益分派。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300030944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0187","BK0028","BK0188","000538","BK0175","BK0196","BK0012","BK0239"],"gpt_icon":0},{"id":"2481670784","title":"11月6日云南白药发布公告,其股东增持1669.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481670784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481670784?lang=zh_cn&edition=full","pubTime":"2024-11-06 20:00","pubTimestamp":1730894459,"startTime":"0","endTime":"0","summary":"证券之星消息,11月6日云南白药发布公告《云南白药:关于股东增持计划时间过半的进展公告》,其股东云南省国有股权运营管理有限公司于2024年8月7日至2024年11月6日间合计增持1669.72万股,占公司目前总股本的0.9358%,变动期间该股股价上涨15.0%,截止11月6日收盘报58.65元。股东增减持详情见下表:根据云南白药2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600034514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0175","000538","BK0187","BK0196","BK0028","BK0164","BK0239","BK0188"],"gpt_icon":0},{"id":"2481674553","title":"云南白药(000538.SZ)第一大股东已累计增持0.98%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2481674553","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481674553?lang=zh_cn&edition=full","pubTime":"2024-11-06 19:31","pubTimestamp":1730892692,"startTime":"0","endTime":"0","summary":"智通财经APP讯,云南白药(000538.SZ)发布公告,截至本公告披露日,本次增持计划时间已经过半。公司第一大股东国有股权管理公司通过深圳证券交易所交易系统以集中竞价交易方式已累计增持公司股份1748.59万股,占公司总股本的比例为0.98%,累计增持金额为人民币9.32亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0012","000538","BK0175","BK0187","BK0196","BK0028","BK0239","BK0164"],"gpt_icon":0},{"id":"2481615513","title":"报告:牙膏市场线上贡献率近四成 参半口腔、云南白药领跑","url":"https://stock-news.laohu8.com/highlight/detail?id=2481615513","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481615513?lang=zh_cn&edition=full","pubTime":"2024-11-06 11:42","pubTimestamp":1730864520,"startTime":"0","endTime":"0","summary":"11月6日上午消息,近日尼尔森发布《全渠道牙膏品类趋势报告》。报告显示,我国牙膏市场全渠道年销售额已达343亿元,其中线上渠道贡献率已近四成。\n 报告还显示,在2023年三季度至2024年一季度,在中国线上牙膏市场中,新消费品牌参半口腔以8.5%市场份额排名首位,与紧随其后的云南白药、好来占据近25%市场份额,形成行业第一梯队。高露洁、宝洁佳洁士分别排名第四、第五。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:江钰涵","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2024-11-06/doc-incvaynm8757741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0175","BK0196","BK0239","000538","BK0012","BK0187","BK0188","BK0164"],"gpt_icon":0},{"id":"2480386324","title":"云南白药第三季度净利润下滑,人事密集调整能否走出高层动荡?","url":"https://stock-news.laohu8.com/highlight/detail?id=2480386324","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480386324?lang=zh_cn&edition=full","pubTime":"2024-11-03 08:07","pubTimestamp":1730592420,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者 林昀肖 北京报道 近日,云南白药发布公告显示,其2024年前三季度实现营业收入299.15亿元,同比增长0.76%;实现归母净利润43.27亿元,同比增长4.93%。单看第三季度,云南白药营业收入仍小幅提升,但归母净利润同比下降12.2%。 云南白药在三季报中指出,单季度的净利润同比下降主要是受非经常性损益影响。 今年以来,云南白药面临高层人事动荡,其近一年来已至少发布4次多个关键岗位的人事变动公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-03/doc-incutwte4483803.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-03/doc-incutwte4483803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000538"],"gpt_icon":0},{"id":"2479537760","title":"云南白药(000538)2024年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2479537760","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479537760?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:29","pubTimestamp":1730327343,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期云南白药发布2024年三季报。根据财报显示,云南白药营收净利润同比双双增长。截至本报告期末,公司营业总收入299.15亿元,同比上升0.76%,归母净利润43.27亿元,同比上升4.93%。报告期内,公司实现营业收入204.55亿元,较上年同期增长0.72%,其中工业收入占营业收入比重进一步提升至37.41%,较上年同期增长0.49个百分点;工业收入增速达2.05%;工业毛利率67.37%,较上年同期增长3.10个百分点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100008200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2479368312","title":"云南白药(000538.SZ)发布前三季度业绩,净利润43.27亿元,同比增长4.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479368312","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479368312?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:33","pubTimestamp":1730219632,"startTime":"0","endTime":"0","summary":"智通财经APP讯,云南白药(000538.SZ)发布2024年三季度报告,前三季度,公司实现营业收入299.15亿元,同比增长0.76%。归属于上市公司股东的净利润43.27亿元,同比增长4.93%。归属于上市公司股东的扣除非经常性损益的净利润42.65亿元,同比增长10.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1203227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000538"],"gpt_icon":0},{"id":"2479850502","title":"云南白药最新公告:第三季度净利润为11.38亿元 同比下降12.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479850502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479850502?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:55","pubTimestamp":1730210139,"startTime":"0","endTime":"0","summary":"云南白药公告,第三季度营收为94.6亿元,同比增长0.86%;净利润为11.38亿元,同比下降12.16%。前三季度营收为299.15亿元,同比增长0.76%;净利润为43.27亿元,同比增长4.93%。公司特别分红方案为向全体股东每10股派发现金红利12.13元(含税)。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900041149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2477514914","title":"云南白药:建链、数字化与新纪元│信心中国·英华万里行","url":"https://stock-news.laohu8.com/highlight/detail?id=2477514914","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477514914?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:13","pubTimestamp":1729732380,"startTime":"0","endTime":"0","summary":"三七和重楼是云南省最具代表性的两种道地药材,也是云南白药中药材数字化成功的代表。今年3月,由云南白药和华为联合打造的中医药大模型正式亮相。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656160259&idx=2&sn=3b6b3e6394da58887565b940d7a09d78&chksm=8ada078face67d01a6951f2e3bc1183dd8ac9e55d75dfb6dc16e808677fe46b6bb46da9b6011&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656160259&idx=2&sn=3b6b3e6394da58887565b940d7a09d78&chksm=8ada078face67d01a6951f2e3bc1183dd8ac9e55d75dfb6dc16e808677fe46b6bb46da9b6011&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0188","BK0187","BK0239","BK0028","BK0175","BK0164","000538","BK0196"],"gpt_icon":0},{"id":"2474906402","title":"云南白药最新公告:聘任李胜利为公司高级副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2474906402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474906402?lang=zh_cn&edition=full","pubTime":"2024-10-11 19:00","pubTimestamp":1728644428,"startTime":"0","endTime":"0","summary":"云南白药公告,公司于2024年10月11日召开第十届董事会2024年第九次会议,审议通过《关于聘任公司高级管理人员的议案》。根据《公司章程》的规定,由公司首席执行官提名,并经董事会提名委员会对被提名人进行任职资格审核,公司董事会同意聘任李胜利担任公司高级副总裁,任期自本次董事会审议通过之日起至第十届董事会届满为止。李胜利未持有本公司股份,不存在不得提名为高级管理人员的情形。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100031891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","BK0012","BK0175","BK0187","000538","BK0164","BK0196"],"gpt_icon":0},{"id":"2474821629","title":"10月9日云南白药跌7.39%,易方达沪深300医药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474821629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474821629?lang=zh_cn&edition=full","pubTime":"2024-10-09 17:12","pubTimestamp":1728465166,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日云南白药跌7.39%,收盘报58.05元,换手率1.73%,成交量30.58万手,成交额18.26亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共46家,其中持有数量最多的公募基金为易方达沪深300医药ETF。易方达沪深300医药ETF目前规模为170.97亿元,最新净值0.4354,较上一交易日上涨8.88%,近一年上涨1.82%。易方达沪深300医药ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900030851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399300","BK0012","159919","BK0164","BK0196","BK0239","512300","000001.SH","BK0187","BK0188","000538","BK0175","BK0028"],"gpt_icon":0},{"id":"2468364966","title":"云南白药:9月19日接受机构调研,招商基金、海通证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2468364966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468364966?lang=zh_cn&edition=full","pubTime":"2024-09-20 19:05","pubTimestamp":1726830346,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月20日云南白药发布公告称公司于2024年9月19日接受机构调研,招商基金周雨婷 张西林 苏超 王奇玮 李佳存 汪彦初 姚飞军、海通证券张澄参与。2023年,云南白药分红方案为每10股派息20.77元,现金分红总额37.06亿元,占2023年归母净利润比例90.53%,公司已于2024年5月10日完成年度权益分派。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092000032741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0012","BK0188","BK0183","BK0276","BK1564","06837","BK0187","600837","BK0239","BK1147","BK0028","BK0164","BK0175","000538","BK0196"],"gpt_icon":0},{"id":"2467386260","title":"云南白药:9月12日接受机构调研,南方基金、博时基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2467386260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467386260?lang=zh_cn&edition=full","pubTime":"2024-09-14 06:25","pubTimestamp":1726266330,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月13日云南白药发布公告称公司于2024年9月12日接受机构调研,南方基金章晖 郭东谋 卢玉珊 何文欣 秦干一 陈逸、博时基金陈西铭 李佳 张治业、中信建投证券刘若飞 许舒枫参与。白药系列核心产品保持稳健增长,其中云南白药气雾剂销售收入超过12亿元,同比增长超30%,云南白药膏、云南白药胶囊销售收入均保持良好增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400004884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0175","000538","BK0187","BK0196","BK0028","BK0164","BK0239","BK0188"],"gpt_icon":0},{"id":"2464849698","title":"云南白药“窝案”后,白云山前董事长李楚源、前董事张春波也遭调查!","url":"https://stock-news.laohu8.com/highlight/detail?id=2464849698","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464849698?lang=zh_cn&edition=full","pubTime":"2024-09-02 17:45","pubTimestamp":1725270300,"startTime":"0","endTime":"0","summary":"9月1日晚,白云山又公告称,张春波“因个人原因”,辞去董事等职务,不再担任公司任何职务。 8月30日,据广东省纪委监委官方公众号消息,广州医药集团有限公司原党委书记、董事长李楚源涉嫌严重违纪违法,正接受广东省纪委监委纪律审查和监察调查。李楚源未持有白云山股份,其离任后,副董事长杨军将代为履行董事长职责,直至选举新任董事长。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-09-02/doc-incmuhuk1042681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","BK0097","BK1521","BK0239","BK0028","BK0188","BK1191","BK0096","BK1197","600332","000538","BK0187","BK0164","BK0012","BK0175","00874","BK1606","BK0183","BK1515","BK0070"],"gpt_icon":0},{"id":"2463772441","title":"换帅之后业绩创历史新高,云南白药做对了什么","url":"https://stock-news.laohu8.com/highlight/detail?id=2463772441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463772441?lang=zh_cn&edition=full","pubTime":"2024-08-31 19:14","pubTimestamp":1725102860,"startTime":"0","endTime":"0","summary":"8月26日,云南白药发布2024年半年度报告,上半年实现营业收入204.55亿元,归母净利润31.89亿元,同比增长12.76%;经营活动现金流净额32.61亿元,同比增长44.82%,业绩创历史新高,交出了令人满意的靓丽答卷。云南白药是有120年历史的老企业,在经济环境下行压力较大的背景下,为什么能够不旦经营业绩创历史新高,还能推动企业实现科技创新驱动的高质量发展转型,云南白药做对了什么?云南白药经营业绩创新高且转型发展顺利,未来可期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024083100014053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0239","BK0196","BK0187","BK0188","BK0012","BK0164","000538"],"gpt_icon":0},{"id":"2462297459","title":"【工信部到云南白药集团调研】金十数据8月28日讯,据云南白药消息,8月23日,工信部消费品工业司副司长王孝洋一行在云南省工信厅相关负责人的陪同下到云南白药集团调研,进一步了解云南省医药产业发展情况,推动云南省医药产业高质量发展。","url":"https://stock-news.laohu8.com/highlight/detail?id=2462297459","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462297459?lang=zh_cn&edition=full","pubTime":"2024-08-28 19:49","pubTimestamp":1724845764,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0175","BK0196","BK0188","BK0012","BK0239","BK0187","BK0164","000538","BK0028"],"gpt_icon":0},{"id":"2462630128","title":"云南白药(000538)2024年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2462630128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462630128?lang=zh_cn&edition=full","pubTime":"2024-08-28 06:13","pubTimestamp":1724796801,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期云南白药发布2024年中报。截至本报告期末,公司营业总收入204.55亿元,同比上升0.72%,归母净利润31.89亿元,同比上升12.76%。本报告期云南白药盈利能力上升,毛利率同比增幅6.32%,净利率同比增幅12.06%。2023年,云南白药分红方案为每10股派息20.77元,现金分红总额37.06亿元,占2023年归母净利润比例90.53%,公司已于2024年5月10日完成年度权益分派。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800007293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2462155695","title":"云南白药(000538)6月30日股东户数17.71万户,较上期减少8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462155695","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462155695?lang=zh_cn&edition=full","pubTime":"2024-08-27 17:05","pubTimestamp":1724749502,"startTime":"0","endTime":"0","summary":"证券之星消息,近日云南白药披露,截至2024年6月30日公司股东户数为17.71万户,较3月31日减少1.55万户,减幅为8.03%。在中药行业个股中,云南白药股东户数高于行业平均水平,截至6月30日,中药行业平均股东户数为5.03万户。从股价来看,2024年3月31日至2024年6月30日,云南白药区间涨幅为4.54%,在此期间股东户数减少1.55万户,减幅为8.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700029140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0012","BK0164","BK0028","BK0188","BK0187","000538","BK0239","BK0175"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","stockEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":0.0056},{"period":"3month","weight":0.0686},{"period":"6month","weight":0.0863},{"period":"1year","weight":0.2041},{"period":"ytd","weight":0.2193}],"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","perCapita":"10255股","boardName":"医药制造业","registeredCapital":"178426万元","compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0121},{"period":"3month","weight":0.1488},{"period":"6month","weight":0.0544},{"period":"1year","weight":0.0752},{"period":"ytd","weight":0.0957}],"survey":" 云南白药集团股份有限公司是一家主要经营化学原料药、化学药制剂、中成药、中药材、生物制品等的公司。公司产品以云南白药系列、三七系列和云南民族特色药品系列为主,共17种剂型200余个产品,产品畅销国内市场及东南亚一带,并逐渐进入日本、欧美等发达国家市场。公司是我国知名中成药生产企业之一,是云南大型工商医药企业之一,是中国中成药五十强之一。2022年12月,由北京大学社会调查研究中心和智联招聘联合主办的“中国年度最佳雇主”评选揭晓,云南白药集团荣膺“2022中国最佳雇主”殊荣。","serverTime":1732662672052,"listedPrice":3.38,"stockholders":"172527人(较上一季度减少2.60%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}